Answers are grounded in this paper and cite their sources.
Our findings suggest that deprescribing in older patients with LLI and LLE can improve medication appropriateness, and has potential for enhancement of several clinical outcomes and cost savings, but the evidence needs to be better established.
No takes yet. Share an insight, caveat, or question.
Shrestha et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: